WO2026111965 - PDE4 INHIBITORS FOR THE TREATMENT OF DISEASES
National phase entry is expected:
Publication Number
WO/2026/111965
Publication Date
28.05.2026
International Application No.
PCT/US2025/055449
International Filing Date
14.11.2025
Title **
[English]
PDE4 INHIBITORS FOR THE TREATMENT OF DISEASES
[French]
INHIBITEURS DE PDE4 POUR LE TRAITEMENT DE MALADIES
Applicants **
ZHU, Yihui
Inventors
ZHU, Yihui
Priority Data
63/722,108
19.11.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2011 | |
| EPO | Filing, Examination, Granting | 8745 | |
| Japan | Filing, Examination, Granting | 1976 | |
| South Korea | Filing, Examination, Granting | 1728 | |
| USA | Filing, Examination, Granting | 4910 |
Total:
19,370
Contact Us
Abstract[English]
Disclosed herein are novel compounds, geometric isomers thereof, or pharmaceutically acceptable salts thereof, which are selective PDE4 inhibitors. Also disclosed are methods of treating diseases or conditions associated with mis-regulation of PDE4.[French]
L'invention concerne de nouveaux composés, des isomères géométriques de ceux-ci, ou des sels pharmaceutiquement acceptables de ceux-ci, qui sont des inhibiteurs sélectifs de PDE4. L'invention concerne également des méthodes de traitement de maladies ou d'états associés à une mauvaise régulation de PDE4.